Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. We’ve got a hurricane-centric newsletter for you
A new NIH program will allocate nearly $30 million to 10 groups over five years to examine the impact of ableism on various health outcomes for
Schizophrenia is a poorly understood illness, but scientists now have greater insight into one of the disorder’s hallmarks, auditory hallucinations, thanks to new research published
Nearly 20 years after neuroscientist John Donoghue placed electrodes on Matthew Nagle’s motor cortex, allowing the man with no limb movement to control objects using
On July 1st, 1995, the world’s spotlight shone upon Yale’s football stadium in New Haven, Connecticut. It was the latest Special Olympics World Games, and
Seven years after the FDA approved Luxterna, scientists have yet to bring another congenital blindness treatment to the market. A team of researchers from the
Elite athletes train and compete under a watchful eye. Fans and coaches track and measure every step, roll, or throw. But for athletes with a
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Hello! Timmy here. I will be spending
Depression has many faces. Some people can’t sleep, while others struggle to get out of bed. Even though symptoms and severity can vary from person
A year ago, after much fanfare and controversy, the Food and Drug Administration approved Eisai and Biogen’s lecanemab, an anti-amyloid drug that moderately slowed cognitive